Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 0093-5002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide (NDC 0093-5002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Olmesartan Medoxomil, Amlodipine, And Hydrochlorothiazide Tablets 40 mg/10 mg/25 mg, 90s Label (Image 10)

Olmesartan Medoxomil, Amlodipine, And Hydrochlorothiazide Tablets 40 mg/10 mg/25 mg, 90s Label (Image 10)
This is a medication with the National Drug Code (NDC) of 0053-5002-55. The medication contains a combination of Olmesartan, WMedoxomil, Amlodipine, and Hydrochlorothiazide. The tablets are in strength of 40 mg of Olmesartan, 10 mg of Amlodipine, and 25 mg of Hydrochlorothiazide. The number 13 appears to indicate that there are only 13 tablets in the package or quantity.*
FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

Image 4
This text appears to be a chart or graph showing the time post-dose and the percentage of OM40/ANLTO, AML10/HCTZ25, and OM40/AML10/HCTZ25. The chart has labels for different time intervals, ranging from 0 to 24 hours post-dose. It is not clear what the context of this chart is, as there is no additional information provided.*
FDA Label Image

Image 5

Image 5
This appears to be a graph showing Mean Ambulatory Systolic Blood Pressure in mmHg over time (in hours post dose). The x-axis shows the time intervals at 4, 8, 12, 16, 20, and 24 hours post dose. The y-axis shows Mean Ambulatory Systolic Blood Pressure in mmHg. There are three lines plotted on the graph labeled Baseline % OV40/AML10, AML10/HCTZ25, and OM40/AML10/HCTZ25.*
FDA Label Image

Image 6

Image 6
This is a description of a medication with NDC number 0053500555. This medication is a combination of Olmesartan medoxomil, Amlodipine, and Hydrochlorothiazide and comes in the form of tablets. The dosage strength of this medication is 20 mg/5 mg/12.5 mg and is only available by prescription (denoted by "B only"). There is a serialization coding area on the packaging.*
FDA Label Image

Image 7

Image 7
This is a description of a prescription drug identified by its NDC (National Drug Code) number as 0055500655. The drug's name is Olmesartan Medoxomil combined with Amlodipine and Hydrochlorothiazide. It comes in tablet form with a strength of 40 mg/5mg/12.5 mg. The text mentions a serial code area for identification purposes.*
FDA Label Image

Image 8

Image 8
This is a packaging label for tablets containing Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide. The strength of this tablet is 40 mg of olmesartan, 5 mg of amlodipine, and 25 mg of hydrochlorothiazide. The label does not provide any further information except for a code for serialization.*
FDA Label Image

Image 9

Image 9
This is a description of a medication called Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets. The tablets contain 40 mg of Olmesartan, 10 mg of Amlodipine, and 12.5 mg of Hydrochlorothiazide, and the National Drug Code (NDC) is 0053-5003-55. The first line might refer to the manufacturer or the lot number, but it is not clear from the available text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.